Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Computers in Biology and Medicine|November 25, 2025
Metabolomic and machine learning enhances patient diagnosis and stratification in systemic autoimmune diseasesCarlos Perez-Sanchez, Antonio Perez-Campoamor, Gema Dolores García-Delgado, et al.Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.Annals of the Rheumatic Diseases|October 9, 2021
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapyAlejandro Ibáñez-Costa, Carlos Perez-Sanchez, Alejandra María Patiño-Trives, et al.Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.Frontiers in Immunology|April 9, 2021
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid ArthritisMaria Luque-Tévar, Carlos Perez-Sanchez, Alejandra Mª Patiño-Trives, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 13, 2024
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibsLaura Muñoz-Barrera, Carlos Perez-Sanchez, Rafaela Ortega-Castro, et al.Lupus|April 3, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")Zeynep Belce Erton, Rebecca K Leaf, Danieli de Andrade, et al.Seminars in Arthritis and Rheumatism|January 7, 2024
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")Cecile M Yelnik, Zeynep Belce Erton, Elodie Drumez, et al.Scientific Reports|April 29, 2025
DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case-control studyBartosz Kaczmarczyk, Carlos de la Calle-Fabregat, Adrian Conde, et al.Pageof 4